Pediatric Oncology Branch, National Cancer Institute, Bethesda, MD, USA.
Cell Death Dis. 2022 Oct 15;13(10):871. doi: 10.1038/s41419-022-05314-6.
The neural crest lineage regulatory transcription factors (TFs) form a core regulatory circuitry (CRC) in neuroblastoma (NB) to specify a noradrenergic tumor phenotype. Oncogenic subversion of CRC TFs is well documented, but the role of loss of tumor suppressors plays remains unclear. Zinc-finger TF CASZ1 is a chromosome 1p36 (chr1p36) tumor suppressor. Single-cell RNA sequencing data analyses indicate that CASZ1 is highly expressed in developing chromaffin cells coincident with an expression of NB CRC TFs. In NB tumor cells, the CASZ1 tumor suppressor is silenced while CRC components are highly expressed. We find the NB CRC component HAND2 directly represses CASZ1 expression. ChIP-seq and transcriptomic analyses reveal that restoration of CASZ1 upregulates noradrenergic neuronal genes and represses expression of CRC components by remodeling enhancer activity. Our study identifies that the restored CASZ1 forms a negative feedback regulatory circuit with the established NB CRC to induce noradrenergic neuronal differentiation of NB.
神经嵴谱系调节转录因子(TFs)在神经母细胞瘤(NB)中形成一个核心调节回路(CRC),以指定去甲肾上腺素能肿瘤表型。CRC TFs 的致癌性颠覆得到了充分的证明,但肿瘤抑制因子丧失的作用仍不清楚。锌指 TF CASZ1 是 1 号染色体 1p36(chr1p36)的肿瘤抑制因子。单细胞 RNA 测序数据分析表明,CASZ1 在发育中的嗜铬细胞中高度表达,与 NB CRC TFs 的表达一致。在 NB 肿瘤细胞中,CASZ1 肿瘤抑制因子被沉默,而 CRC 成分高度表达。我们发现,NB CRC 成分 HAND2 直接抑制 CASZ1 的表达。ChIP-seq 和转录组分析显示,CASZ1 的恢复通过重塑增强子活性而上调去甲肾上腺素能神经元基因的表达,并抑制 CRC 成分的表达。我们的研究表明,恢复的 CASZ1 与已建立的 NB CRC 形成负反馈调节回路,诱导 NB 的去甲肾上腺素能神经元分化。